Anika Therapeutics (ANIK) Market Capitalization (2010 - 2026)

Anika Therapeutics (ANIK) has reported Market Capitalization for 17 consecutive years, with $195.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 28.35% year-over-year to $195.8 million in Q2 2026; TTM through Jun 2026 was $195.8 million, a 28.35% increase from a year earlier, with the FY2025 full-year figure at $133.5 million, down 43.75% from the prior year.
• Market Capitalization was $195.8 million for Q2 2026 at Anika Therapeutics, up from $193.7 million in the prior quarter.
• Over five years, Market Capitalization peaked at $432.9 million in Q4 2022 and troughed at $133.5 million in Q4 2025.
• A 5-year average of $292.2 million and a median of $329.0 million in 2022 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization jumped 33.1% in 2024 and sank 62.65% in 2025, its largest moves.
• Over 5 years, Market Capitalization stood at $432.9 million in 2022, then decreased by 23.26% to $332.2 million in 2023, then fell by 28.57% to $237.3 million in 2024, then slumped by 43.75% to $133.5 million in 2025, then soared by 46.69% to $195.8 million in 2026.
• The last three Market Capitalization figures came in at $195.8 million (Q2 2026), $193.7 million (Q1 2026), and $133.5 million (Q4 2025), per Business Quant data.